Headquarters: Foster City, California, United States
Trade prices
Volume:
Market Cap:1.26B
Prev closed:23.76
Open:23.49
High:23.49
Low:22.43
52 week low:17.8
52 week high:58.48
Dividends:No Dividends
Next ER:August 8, 2022
Top Stories (PCVX)
Company Profile
We are a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
We utilize a cell-free protein synthesis platform to enable us to uniquely design and produce protein carriers and antigens, the critical building blocks of vaccines, in ways that we believe conventional vaccine technologies currently cannot.
Talk about Vaxcyte Inc below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.